Literature DB >> 9098543

Cryptic brain cell injury caused by fetal nicotine exposure is associated with persistent elevations of c-fos protooncogene expression.

T A Slotkin1, E C McCook, F J Seidler.   

Abstract

Neurobehavioral teratogenesis caused by prenatal nicotine exposure is associated with deficiencies in brain cell numbers that reflect, in part, effects on cell replication but that also involve delayed cell loss. In the current study, pregnant rats were given nicotine by implanted minipump infusion either from gestational days 4-12 or 4-21 and fetal and neonatal brain regions were examined for expression of the mRNA encoding c-fos, a nuclear transcription factor that becomes chronically elevated when cell injury or apoptosis are occurring. Fetuses exposed to nicotine on gestational days 4-12 did not show elevations of c-fos mRNA on gestational day 18 whereas animals undergoing exposure through day 21 did. In the latter group, elevated c-fos expression was still present on postnatal day 2 despite the cessation of nicotine exposure on gestational day 21. In contrast to the elevation of c-fos seen with prenatal nicotine, postnatal nicotine injections given to 2-day-old rats did not cause acute stimulation of c-fos expression. The ability of injected nicotine to evoke acute rises in c-fos emerged by postnatal day 8 and initially displayed regional specificity paralleling the concentration of nicotinic cholinergic receptors. With increasing maturity, regional selectivity of the c-fos response to acute nicotine was lost, consistent with indirect actions that could be mediated through nicotine-induced hypoxia/ischemia. These results indicate that prenatal nicotine exposure causes chronic elevations of c-fos expression in fetal and neonatal brain that are distinguishable from the later onset of the ability of acute nicotine to cause short-term stimulation of c-fos. The critical period and dose threshold for these effects correspond to those of subsequent cell damage and cell loss identified in previous studies with fetal nicotine exposure. Given that chronic elevations of c-fos are known to be associated with cell injury and to evoke apoptosis in otherwise healthy cells, these results suggest that prenatal nicotine exposure evokes delayed neurotoxicity by altering the program of neural cell differentiation, and that elevated c-fos expression provides an early marker of the eventual deficits.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9098543     DOI: 10.1016/s0006-8993(96)01345-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  Developmental cigarette smoke exposure: hippocampus proteome and metabolome profiles in low birth weight pups.

Authors:  Rachel E Neal; Jing Chen; Rekha Jagadapillai; Hyejeong Jang; Bassam Abomoelak; Guy Brock; Robert M Greene; M Michele Pisano
Journal:  Toxicology       Date:  2014-01-28       Impact factor: 4.221

Review 2.  Smokeless tobacco use in pregnancy: an integrative review of the literature.

Authors:  Angela Ratsch; Fiona Bogossian
Journal:  Int J Public Health       Date:  2014-05-04       Impact factor: 3.380

Review 3.  Developmental toxicity of nicotine: A transdisciplinary synthesis and implications for emerging tobacco products.

Authors:  Lucinda J England; Kjersti Aagaard; Michele Bloch; Kevin Conway; Kelly Cosgrove; Rachel Grana; Thomas J Gould; Dorothy Hatsukami; Frances Jensen; Denise Kandel; Bruce Lanphear; Frances Leslie; James R Pauly; Jenae Neiderhiser; Mark Rubinstein; Theodore A Slotkin; Eliot Spindel; Laura Stroud; Lauren Wakschlag
Journal:  Neurosci Biobehav Rev       Date:  2016-11-24       Impact factor: 8.989

4.  Early exposure to nicotine during critical periods of brain development: Mechanisms and consequences.

Authors:  Andrew M Smith; Linda P Dwoskin; James R Pauly
Journal:  J Pediatr Biochem       Date:  2010

5.  Hypothyroidism induces Fos-like immunoreactivity in ventral medullary neurons that synthesize TRH.

Authors:  P Q Yuan; H Yang
Journal:  Am J Physiol       Date:  1999-11

6.  Synaptogenesis and myopathy under acetylcholinesterase overexpression.

Authors:  E Lev-Lehman; T Evron; R S Broide; E Meshorer; I Ariel; S Seidman; H Soreq
Journal:  J Mol Neurosci       Date:  2000 Feb-Apr       Impact factor: 3.444

Review 7.  Risks and benefits of nicotine to aid smoking cessation in pregnancy.

Authors:  D A Dempsey; N L Benowitz
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

8.  Neurobehavioral phenotype of C57BL/6J mice prenatally and neonatally exposed to cigarette smoke.

Authors:  Robyn M Amos-Kroohs; Michael T Williams; Amanda A Braun; Devon L Graham; Cynthia L Webb; Todd S Birtles; Robert M Greene; Charles V Vorhees; M Michele Pisano
Journal:  Neurotoxicol Teratol       Date:  2013-01-11       Impact factor: 3.763

Review 9.  [Effects of nicotine on neurodevelopment].

Authors:  C Wessels; G Winterer
Journal:  Nervenarzt       Date:  2008-01       Impact factor: 1.214

Review 10.  Gestational exposures to organophosphorus insecticides: From acute poisoning to developmental neurotoxicity.

Authors:  Spencer W Todd; Eric W Lumsden; Yasco Aracava; Jacek Mamczarz; Edson X Albuquerque; Edna F R Pereira
Journal:  Neuropharmacology       Date:  2020-08-16       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.